23-Valent Pneumococcal Polysaccharide Vaccine
23-Valent Pneumococcal Polysaccharide Vaccine
23-Valent Pneumococcal Polysaccharide Vaccine

23-Valent Pneumococcal Polysaccharide Vaccine

23-Valent Pneumococcal Polysaccharide Vaccine
23-Valent Pneumococcal Polysaccharide Vaccine
23-Valent Pneumococcal Polysaccharide Vaccine

23-Valent Pneumococcal Polysaccharide Vaccine

In 2019, it was approved by NMPA, China.

The key project of the science and technique ministry of China. 

 

【Active constituent】

Pneumonia serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 20, 22F, 23F, 33F

【Strengths】

0.5ml per vial. 0.5 ml per single human dose containing 23 serotypes of purified peneumococcal capsular polusaccharde respectively 25 μg.

【Eligibles】

People aged 2 years and above, especially for people who suffer from chronic diseases, who suffer from immunological functions, who are HIV-infected, who with cerebrospinal fluid leak, who live 
or work in a high-risk environment with pneumonia, and who are the elders.

【Shelf Life】

24 months